The humanitarian and filmmaker shares the latest development in her journey to minimize her cancer risk.
Image via Georges Biard/Wikimedia Commons.
Today, Angelina Jolie penned an op-ed for the New York Times frankly discussing her recent surgery to remove her ovaries and fallopian tubes. The operation carried the added weight of kickstarting early menopause despite the hormone replacements Jolie has been taking. It was the latest development in Jolie’s commitment to publicly sharing her courageous efforts to preemptively minimize her chances for cancer, ever since a blood test revealed that she carried the “faulty” BRCA1 gene, which gave Jolie “an estimated 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer.” The humanitarian, filmmaker, and mother of six has been incredibly forthright in disclosing the details of her difficult journey with the world, including the decision to undergo a double mastectomy two years ago. Post-procedure, Jolie reported in another NYT op-ed that her breast cancer risk had “dropped from 87 percent to under 5 percent.”